• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

具有协同树突状细胞靶向作用和增强内体逃逸能力的工程化脂质纳米颗粒,用于增强型mRNA癌症疫苗。

Engineered lipid nanoparticles with synergistic dendritic cell targeting and enhanced endosomal escape for boosted mRNA cancer vaccines.

作者信息

Wang Sizhen, Zheng Jianyu, Zhou Jiao, Jiang Weiwei, Chen Zhendong, Wu Xiaoxian, Guo Beibei, Wu Yanfeng, Yang Feng

机构信息

National Key Laboratory of Immunity and Inflammation & School of Pharmacy, Naval Medical University, Shanghai, 200433, China.

National Key Laboratory of Immunity and Inflammation & Institute of Immunology, College of Basic Medical Sciences, Naval Medical University, Shanghai, 200433, China.

出版信息

Mater Today Bio. 2025 Jul 19;34:102107. doi: 10.1016/j.mtbio.2025.102107. eCollection 2025 Oct.

DOI:10.1016/j.mtbio.2025.102107
PMID:40740252
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12308020/
Abstract

Lipid nanoparticles (LNPs) have emerged as a pivotal carriers for enhancing mRNA therapeutics, particularly in antitumor therapy. However, achieving robust antigen expression remains a major challenge due to limitations in precise targeted delivery and inefficient endosomal escape. In this study, we constructed an ambidextrous LNP to achieve robust tumor-specific antigen expression through targeted cell delivery and enhanced endosomal escape of mRNA-LNPs. To improve endosomal escape, we synthesized a novel pH-responsive PEGylated lipid designed to synergistically enhance membrane fusion effect with ionizable lipids, thereby optimizing the translation of the desired antigen. This is accomplished by promoting the early endosomal escape and endosomal recycling transport. For precise delivery of mRNA-LNPs to dendritic cells, we employed a mannose-modified PEGylated lipid that targets mannose receptors. Our results demonstrated that the combination of mannose-directed targeting and pH-mediated endosomal escape significantly enhances antigen translation and expression, leading to a vigorous immune response, as validated by both in vitro and in vivo experiments. This ambidextrous strategy advances the formulation of LNPs for precise mRNA delivery and effective antigen encoding, facilitating the development of mRNA vaccines in the field of antitumor immunology.

摘要

脂质纳米颗粒(LNPs)已成为增强mRNA疗法的关键载体,尤其是在抗肿瘤治疗中。然而,由于精确靶向递送的局限性和内体逃逸效率低下,实现强大的抗原表达仍然是一个重大挑战。在本研究中,我们构建了一种双功能LNP,通过靶向细胞递送和增强mRNA-LNPs的内体逃逸来实现强大的肿瘤特异性抗原表达。为了改善内体逃逸,我们合成了一种新型的pH响应性聚乙二醇化脂质,旨在与可电离脂质协同增强膜融合效果,从而优化所需抗原的翻译。这是通过促进早期内体逃逸和内体循环运输来实现的。为了将mRNA-LNPs精确递送至树突状细胞,我们采用了一种靶向甘露糖受体的甘露糖修饰聚乙二醇化脂质。我们的结果表明,甘露糖导向的靶向作用和pH介导的内体逃逸相结合,显著增强了抗原翻译和表达,引发了强烈的免疫反应,体外和体内实验均验证了这一点。这种双功能策略推动了用于精确mRNA递送和有效抗原编码的LNPs制剂的发展,促进了抗肿瘤免疫学领域mRNA疫苗的开发。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bb47/12308020/fe412f5ab18c/gr8.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bb47/12308020/fea8ecbfd8cb/ga1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bb47/12308020/309d0dbe98fc/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bb47/12308020/90b6d9d38aac/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bb47/12308020/80b1f4e152a4/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bb47/12308020/20fc48bc0eba/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bb47/12308020/6ce93447e97f/gr5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bb47/12308020/65ed079f51c2/gr6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bb47/12308020/595d0d3c7ca5/gr7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bb47/12308020/fe412f5ab18c/gr8.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bb47/12308020/fea8ecbfd8cb/ga1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bb47/12308020/309d0dbe98fc/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bb47/12308020/90b6d9d38aac/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bb47/12308020/80b1f4e152a4/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bb47/12308020/20fc48bc0eba/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bb47/12308020/6ce93447e97f/gr5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bb47/12308020/65ed079f51c2/gr6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bb47/12308020/595d0d3c7ca5/gr7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bb47/12308020/fe412f5ab18c/gr8.jpg

相似文献

1
Engineered lipid nanoparticles with synergistic dendritic cell targeting and enhanced endosomal escape for boosted mRNA cancer vaccines.具有协同树突状细胞靶向作用和增强内体逃逸能力的工程化脂质纳米颗粒,用于增强型mRNA癌症疫苗。
Mater Today Bio. 2025 Jul 19;34:102107. doi: 10.1016/j.mtbio.2025.102107. eCollection 2025 Oct.
2
Lipid Nanoparticle-Associated Inflammation is Triggered by Sensing of Endosomal Damage: Engineering Endosomal Escape Without Side Effects.脂质纳米颗粒相关的炎症是由内体损伤的感知引发的:设计无副作用的内体逃逸。
bioRxiv. 2024 Apr 18:2024.04.16.589801. doi: 10.1101/2024.04.16.589801.
3
Mechanism of pH-sensitive Amphiphilic Endosomal Escape of Ionizable Lipid Nanoparticles for Cytosolic Nucleic Acid Delivery.用于胞质核酸递送的可电离脂质纳米颗粒的pH敏感两亲性内体逃逸机制
Pharm Res. 2025 Jul 8. doi: 10.1007/s11095-025-03890-8.
4
Impact of ionizable lipid type on the pharmacokinetics and biodistribution of mRNA-lipid nanoparticles after intravenous and subcutaneous injection.可电离脂质类型对静脉注射和皮下注射后mRNA-脂质纳米颗粒的药代动力学和生物分布的影响。
J Control Release. 2025 Aug 10;384:113945. doi: 10.1016/j.jconrel.2025.113945. Epub 2025 Jun 10.
5
Nucleic Acid Nanocapsules as a New Platform to Deliver Therapeutic Nucleic Acids for Gene Regulation.核酸纳米胶囊作为用于基因调控的治疗性核酸递送新平台。
Acc Chem Res. 2025 Jul 1;58(13):1951-1962. doi: 10.1021/acs.accounts.5c00126. Epub 2025 Jun 9.
6
Biodegradable polymers with tertiary amines enhance mRNA delivery of lipid nanoparticles via improved endosomal escape.含有叔胺的可生物降解聚合物通过改善内体逃逸增强脂质纳米颗粒的mRNA递送。
Biomaterials. 2026 Jan;324:123541. doi: 10.1016/j.biomaterials.2025.123541. Epub 2025 Jul 8.
7
TLR7-Adjuvanted Ionizable Lipid Nanoparticles for mRNA Vaccine Delivery.用于mRNA疫苗递送的TLR7佐剂可电离脂质纳米颗粒
AAPS J. 2025 Apr 25;27(4):80. doi: 10.1208/s12248-025-01073-2.
8
Cholesterol-Derived Mannosylated Polypeptide-Formed Lipid Nanoparticles for Efficient in Vivo mRNA Delivery.用于高效体内mRNA递送的胆固醇衍生甘露糖基化多肽形成的脂质纳米颗粒
Small Methods. 2025 Jun;9(6):e2401712. doi: 10.1002/smtd.202401712. Epub 2025 Apr 21.
9
The kinetics of endosomal disruption reveal differences in lipid nanoparticle induced cellular toxicity.内体破坏的动力学揭示了脂质纳米颗粒诱导的细胞毒性差异。
J Control Release. 2025 Jul 18:114047. doi: 10.1016/j.jconrel.2025.114047.
10
Efficacy versus immunogenicity of LNP-mediated delivery of mRNA and self-amplifying RNA upon intravitreal injection in the mouse eye.脂质纳米颗粒介导的mRNA和自扩增RNA玻璃体内注射到小鼠眼中后的疗效与免疫原性
J Control Release. 2025 Jul 12;385:114027. doi: 10.1016/j.jconrel.2025.114027.

本文引用的文献

1
Transforming vaccinology.疫苗学的变革。
Cell. 2024 Sep 19;187(19):5171-5194. doi: 10.1016/j.cell.2024.07.021.
2
Strategies and mechanisms for endosomal escape of therapeutic nucleic acids.治疗性核酸的内体逃逸策略和机制。
Curr Opin Chem Biol. 2024 Aug;81:102506. doi: 10.1016/j.cbpa.2024.102506. Epub 2024 Aug 2.
3
Cancer mRNA vaccines: clinical advances and future opportunities.癌症 mRNA 疫苗:临床进展和未来机遇。
Nat Rev Clin Oncol. 2024 Jul;21(7):489-500. doi: 10.1038/s41571-024-00902-1. Epub 2024 May 17.
4
mRNA-based therapeutics: looking beyond COVID-19 vaccines.mRNA 疗法:超越 COVID-19 疫苗的展望。
Lancet. 2024 Mar 23;403(10432):1192-1204. doi: 10.1016/S0140-6736(23)02444-3. Epub 2024 Mar 7.
5
Endosomal escape: A bottleneck for LNP-mediated therapeutics.内涵体逃逸:LNP 介导治疗的瓶颈。
Proc Natl Acad Sci U S A. 2024 Mar 12;121(11):e2307800120. doi: 10.1073/pnas.2307800120. Epub 2024 Mar 4.
6
Inhalable extracellular vesicle delivery of IL-12 mRNA to treat lung cancer and promote systemic immunity.吸入式细胞外囊泡传递 IL-12 mRNA 治疗肺癌并促进全身免疫。
Nat Nanotechnol. 2024 Apr;19(4):565-575. doi: 10.1038/s41565-023-01580-3. Epub 2024 Jan 11.
7
MHC cross-dressing in antigen presentation.MHC 分子在抗原呈递中的交叉呈递。
Adv Immunol. 2023;159:115-147. doi: 10.1016/bs.ai.2023.07.001. Epub 2023 Nov 4.
8
Simultaneous dendritic cells targeting and effective endosomal escape enhance sialic acid-modified mRNA vaccine efficacy and reduce side effects.同时靶向树突状细胞和有效逃逸内涵体可增强唾液酸化 mRNA 疫苗的疗效并降低副作用。
J Control Release. 2023 Dec;364:529-545. doi: 10.1016/j.jconrel.2023.11.008. Epub 2023 Nov 11.
9
IL-27p28 specifically regulates MHC II expression in macrophages through CIITA.白细胞介素 27p28 通过 CIITA 特异性调节巨噬细胞中的 MHC II 表达。
Immunobiology. 2023 Nov;228(6):152757. doi: 10.1016/j.imbio.2023.152757. Epub 2023 Nov 1.
10
Enabling mRNA Therapeutics: Current Landscape and Challenges in Manufacturing.mRNA 疗法的实现:当前的制造现状和挑战。
Biomolecules. 2023 Oct 9;13(10):1497. doi: 10.3390/biom13101497.